The in vitro Biochemical Characterization of an HIV-1 Restriction Factor APOBEC3F: Importance of Loop 7 on Both CD1 and CD2 for DNA Binding and Deamination

Journal of Molecular Biology

Volumn 428, Issue 13, 2016, Pages 2661-2670

  Chen, Qihan ^a   Xiao, Xiao ^a   Wolfe, Aaron ^a   Chen, Xiaojiang S ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Anti HIV; APOBEC deaminases; APOBEC3F; DNA binding

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3F; BACTERIAL DNA; CD1 ANTIGEN; CD2 ANTIGEN; DEAMINASE; MUTANT PROTEIN; CYTOSINE DEAMINASE; DNA BINDING PROTEIN; ESCHERICHIA COLI PROTEIN; PROTEIN BINDING; SINGLE STRANDED DNA;

ARTICLE; BACTERIAL GENETICS; BIOCHEMICAL ANALYSIS; CONTROLLED STUDY; DEAMINATION; DNA BINDING; ENZYME ACTIVITY; ENZYME PURIFICATION; ESCHERICHIA COLI; GENE EXPRESSION SYSTEM; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; WILD TYPE; GENETICS; METABOLISM;

CYTOSINE DEAMINASE; DEAMINATION; DNA, SINGLE-STRANDED; DNA-BINDING PROTEINS; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; HIV-1; PROTEIN BINDING; PROTEIN DOMAINS;

EID: 84971215822     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2016.03.031     Document Type: Article

References (65)

1. A. Jarmuz, A. Chester, J. Bayliss, J. Gisbourne, I. Dunham, J. Scott, and N. Navaratnam An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22 Genomics 79 2002 285 296
2. R. Bransteitter, C. Prochnow, and X.S. Chen The current structural and functional understanding of APOBEC deaminases Cell. Mol. Life Sci. 66 2009 3137 3147
3. S.G. Conticello The AID/APOBEC family of nucleic acid mutators Genome Biol. 9 2008 229
4. R.S. Harris, K.N. Bishop, A.M. Sheehy, H.M. Craig, S.K. Petersen-Mahrt, I.N. Watt, M.S. Neuberger, and M.H. Malim DNA deamination mediates innate immunity to retroviral infection Cell 113 2003 803 809
5. X.F. Yu Innate cellular defenses of APOBEC3 cytidine deaminases and viral counter-defenses Curr. Opin. HIV AIDS 1 2006 187 193
6. C. Prochnow, R. Bransteitter, and X.S. Chen APOBEC deaminases-mutases with defensive roles for immunity Sci. China C Life Sci. 52 2009 893 902
7. R.S. Harris, and M.T. Liddament Retroviral restriction by APOBEC proteins Nat. Rev. Immunol. 4 2004 868 877
8. N.K. Duggal, and M. Emerman Evolutionary conflicts between viruses and restriction factors shape immunity Nat. Rev. Immunol. 12 2012 687 695
9. A. Moris, S. Murray, and S. Cardinaud AID and APOBECs span the gap between innate and adaptive immunity Front. Microbiol. 5 2014 534
10. A. Koito, and T. Ikeda Intrinsic immunity against retrotransposons by APOBEC cytidine deaminases Front. Microbiol. 4 2013 28
11. B.K. Thielen, J.P. McNevin, M.J. McElrath, B.V.S. Hunt, K.C. Klein, and J.R. Lingappa Innate immune signaling induces high levels of TC-specific deaminase activity in primary monocyte-derived cells through expression of APOBEC3A isoforms J. Biol. Chem. 285 2010 27753 27766
12. R.A. Russell, J. Smith, R. Barr, D. Bhattacharyya, and V.K. Pathak Distinct domains within APOBEC3G and APOBEC3F interact with separate regions of human immunodeficiency virus type 1 Vif J. Virol. 83 2009 1992 2003
13. M.A. Farrow, and A.M. Sheehy Vif and Apobec3G in the innate immune response to HIV: a tale of two proteins Future Microbiol 3 2008 145 154
14. R.A. Russell, and V.K. Pathak Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F J. Virol. 81 2007 8201 8210
15. A. Takaori-Kondo APOBEC family proteins: novel antiviral innate immunity Int. J. Hematol. 83 2006 213 216
16. S.J. Cho, H. Drechsler, R.C. Burke, M.Q. Arens, W. Powderly, and N.O. Davidson APOBEC3F and APOBEC3G mRNA levels do not correlate with human immunodeficiency virus type 1 plasma viremia or CD4 + T-cell count J. Virol. 80 2006 2069 2072
17. Y.H. Zheng, D. Irwin, T. Kurosu, K. Tokunaga, T. Sata, and B.M. Peterlin Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication J. Virol. 78 2004 6073 6076
18. M.B. Burns, L. Lackey, M.A. Carpenter, A. Rathore, A.M. Land, B. Leonard, E.W. Refsland, D. Kotandeniya, N. Tretyakova, J.B. Nikas, D. Yee, N.A. Temiz, D.E. Donohue, R.M. McDougle, W.L. Brown, E.K. Law, and R.S. Harris APOBEC3B is an enzymatic source of mutation in breast cancer Nature 494 2013 366 370
19. M.B. Burns, N.A. Temiz, and R.S. Harris Evidence for APOBEC3B mutagenesis in multiple human cancers Nat. Genet. 45 2013 977 983
20. S. Nik-Zainal, D.C. Wedge, L.B. Alexandrov, M. Petljak, A.P. Butler, N. Bolli, H.R. Davies, S. Knappskog, S. Martin, E. Papaemmanuil, M. Ramakrishna, A. Shlien, I. Simonic, Y. Xue, C. Tyler-Smith, P.J. Campbell, and M.R. Stratton Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer Nat. Genet. 46 2014 487 491
21. S.A. Roberts, M.S. Lawrence, L.J. Klimczak, S.A. Grimm, D. Fargo, P. Stojanov, A. Kiezun, G.V. Kryukov, S.L. Carter, G. Saksena, S. Harris, R.R. Shah, M.A. Resnick, G. Getz, and D.A. Gordenin An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers Nat. Genet. 45 2013 970 976
22. S.G. Conticello Creative deaminases, self-inflicted damage, and genome evolution Ann. N. Y. Acad. Sci. 1267 2012 79 85
23. J.U. Guo, Y. Su, C. Zhong, G.L. Ming, and H. Song Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain Cell 145 2011 423 434
24. S. Nik-Zainal, L.B. Alexandrov, D.C. Wedge, P. Van Loo, C.D. Greenman, K. Raine, D. Jones, J. Hinton, J. Marshall, L.A. Stebbings, A. Menzies, S. Martin, K. Leung, L. Chen, C. Leroy, M. Ramakrishna, R. Rance, K.W. Lau, L.J. Mudie, I. Varela, D.J. McBride, G.R. Bignell, S.L. Cooke, A. Shlien, J. Gamble, I. Whitmore, M. Maddison, P.S. Tarpey, H.R. Davies, E. Papaemmanuil, P.J. Stephens, S. McLaren, A.P. Butler, J.W. Teague, G. Jonsson, J.E. Garber, D. Silver, P. Miron, A. Fatima, S. Boyault, A. Langerod, A. Tutt, J.W. Martens, S.A. Aparicio, A. Borg, A.V. Salomon, G. Thomas, A.L. Borresen-Dale, A.L. Richardson, M.S. Neuberger, P.A. Futreal, P.J. Campbell, and M.R. Stratton Mutational processes molding the genomes of 21 breast cancers Cell 149 2012 979 993
25. S.G. Conticello, R.S. Harris, and M.S. Neuberger The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G Curr. Biol. 13 2003 2009 2013
26. R. Mariani, D. Chen, B. Schrofelbauer, F. Navarro, R. Konig, B. Bollman, C. Munk, H. Nymark-McMahon, and N.R. Landau Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif Cell 114 2003 21 31
27. A.M. Sheehy, N.C. Gaddis, and M.H. Malim The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif Nat. Med. 9 2003 1404 1407
28. X. Wang, P.T. Dolan, Y. Dang, and Y.H. Zheng Biochemical differentiation of APOBEC3F and APOBEC3G proteins associated with HIV-1 life cycle J. Biol. Chem. 282 2007 1585 1594
29. M.T. Liddament, W.L. Brown, A.J. Schumacher, and R.S. Harris APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo Curr. Biol. 14 2004 1385 1391
30. K. Belanger, and M.A. Langlois Comparative analysis of the gene-inactivating potential of retroviral restriction factors APOBEC3F and APOBEC3G J. Gen. Virol. 96 2015 2878 2887
31. X. Wang, X. Li, J. Ma, L. Zhang, L. Ma, Z. Mi, J. Zhou, F. Guo, L. Kleiman, and S. Cen Human APOBEC3F incorporation into human immunodeficiency virus type 1 particles Virus Res. 191C 2014 30 38
32. C. Song, L. Sutton, M.E. Johnson, R.T. D'Aquila, and J.P. Donahue Signals in APOBEC3F N-terminal and C-terminal deaminase domains each contribute to encapsidation in HIV-1 virions and are both required for HIV-1 restriction J. Biol. Chem. 287 2012 16965 16974
33. V. Zennou, D. Perez-Caballero, H. Gottlinger, and P.D. Bieniasz APOBEC3G incorporation into human immunodeficiency virus type 1 particles J. Virol. 78 2004 12058 12061
34. T. Wang, C. Tian, W. Zhang, P.T. Sarkis, and X.F. Yu Interaction with 7SL RNA but not with HIV-1 genomic RNA or P bodies is required for APOBEC3F virion packaging J. Mol. Biol. 375 2008 1098 1112
35. F. Navarro, B. Bollman, H. Chen, R. Konig, Q. Yu, K. Chiles, and N.R. Landau Complementary function of the two catalytic domains of APOBEC3G Virology 333 2005 374 386
36. X. Li, J. Ma, Q. Zhang, J. Zhou, X. Yin, C. Zhai, X. You, L. Yu, F. Guo, L. Zhao, Z. Li, Y. Zeng, and S. Cen Functional analysis of the two cytidine deaminase domains in APOBEC3G Virology 414 2011 130 136
37. T. Wang, C. Tian, W. Zhang, K. Luo, P.T. Sarkis, L. Yu, B. Liu, Y. Yu, and X.F. Yu 7SL RNA mediates virion packaging of the antiviral cytidine deaminase APOBEC3G J. Virol. 81 2007 13112 13124
38. L. Apolonia, R. Schulz, T. Curk, P. Rocha, C.M. Swanson, T. Schaller, J. Ule, and M.H. Malim Promiscuous RNA binding ensures effective encapsidation of APOBEC3 proteins by HIV-1 PLoS Pathog. 11 2015 e1004609
39. J.P. Donahue, R.T. Levinson, J.H. Sheehan, L. Sutton, H.E. Taylor, J. Meiler, R.T. D'Aquila, and C. Song Genetic analysis of the localization of APOBEC3F to human immunodeficiency virus type 1 virion cores J. Virol. 89 2015 2415 2424
40. B. Liu, P.T. Sarkis, K. Luo, Y. Yu, and X.F. Yu Regulation of Apobec3F and human immunodeficiency virus type 1 Vif by Vif-Cul5-ElonB/C E3 ubiquitin ligase J. Virol. 79 2005 9579 9587
41. J.L. Smith, and V.K. Pathak Identification of specific determinants of human APOBEC3F, APOBEC3C, and APOBEC3DE and African green monkey APOBEC3F that interact with HIV-1 Vif J. Virol. 84 2010 12599 12608
42. M. Nakashima, H. Ode, T. Kawamura, S. Kitamura, Y. Naganawa, H. Awazu, S. Tsuzuki, K. Matsuoka, M. Nemoto, A. Hachiya, W. Sugiura, Y. Yokomaku, N. Watanabe, and Y. Iwatani Structural Insights into HIV-1 Vif-APOBEC3F Interaction J. Virol. 2015
43. K.K. Siu, A. Sultana, F.C. Azimi, and J.E. Lee Structural determinants of HIV-1 Vif susceptibility and DNA binding in APOBEC3F Nat. Commun. 4 2013 2593
44. R.K. Holmes, F.A. Koning, K.N. Bishop, and M.H. Malim APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G J. Biol. Chem. 282 2007 2587 2595
45. H. Aydin, M.W. Taylor, and J.E. Lee Structure-guided analysis of the human APOBEC3-HIV restrictome Structures 22 2014 668 684
46. M.D. Stenglein, and R.S. Harris APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism J. Biol. Chem. 281 2006 16837 16841
47. K. Bélanger, M. Savoie, M.C. Rosales Gerpe, J.-F. Couture, and M.-A. Langlois Binding of RNA by APOBEC3G controls deamination-independent restriction of retroviruses Nucleic Acids Res. 41 2013 7438 7452
48. J.S. Albin, W.L. Brown, and R.S. Harris Catalytic activity of APOBEC3F is required for efficient restriction of Vif-deficient human immunodeficiency virus Virology 450-451 2014 49 54
49. J.L. Mbisa, W. Bu, and V.K. Pathak APOBEC3F and APOBEC3G inhibit HIV-1 DNA integration by different mechanisms J. Virol. 84 2010 5250 5259
50. M. Monajemi, C.F. Woodworth, K. Zipperlen, M. Gallant, M.D. Grant, and M. Larijani Positioning of APOBEC3G/F mutational hotspots in the human immunodeficiency virus genome favors reduced recognition by CD8 + T cells PLoS One 9 2014 e93428
51. Y. Hakata, and N.R. Landau Reversed functional organization of mouse and human APOBEC3 cytidine deaminase domains J. Biol. Chem. 281 2006 36624 36631
52. L.G. Holden, C. Prochnow, Y.P. Chang, R. Bransteitter, L. Chelico, U. Sen, R.C. Stevens, M.F. Goodman, and X.S. Chen Crystal structure of the anti-viral APOBEC3G catalytic domain and functional implications Nature 456 2008 121 124
53. E.N. Newman, R.K. Holmes, H.M. Craig, K.C. Klein, J.R. Lingappa, M.H. Malim, and A.M. Sheehy Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity Curr. Biol. 15 2005 166 170
54. Y. Fu, F. Ito, G. Zhang, B. Fernandez, H. Yang, and X.S. Chen DNA cytosine and methylcytosine deamination by APOBEC3B: enhancing methylcytosine deamination by engineering APOBEC3B Biochem. J. 2015
55. E.C. Logue, N. Bloch, E. Dhuey, R. Zhang, P. Cao, C. Herate, L. Chauveau, S.R. Hubbard, and N.R. Landau A DNA sequence recognition loop on APOBEC3A controls substrate specificity PLoS One 9 2014
56. A. Rathore, M.A. Carpenter, O. Demir, T. Ikeda, M. Li, N.M. Shaban, E.K. Law, D. Anokhin, W.L. Brown, R.E. Amaro, and R.S. Harris The local dinucleotide preference of APOBEC3G can be altered from 5′-CC to 5′-TC by a single amino acid substitution J. Mol. Biol. 425 2013 4442 4454
57. M. Wang, C. Rada, and M.S. Neuberger Altering the spectrum of immunoglobulin V gene somatic hypermutation by modifying the active site of AID J. Exp. Med. 207 2010 141 153
58. M. Mitra, K. Hercik, I.J. Byeon, J. Ahn, S. Hill, K. Hinchee-Rodriguez, D. Singer, C.H. Byeon, L.M. Charlton, G. Nam, G. Heidecker, A.M. Gronenborn, and J.G. Levin Structural determinants of human APOBEC3A enzymatic and nucleic acid binding properties Nucleic Acids Res. 42 2014 1095 1110
59. I.J. Byeon, J. Ahn, M. Mitra, C.H. Byeon, K. Hercik, J. Hritz, L.M. Charlton, J.G. Levin, and A.M. Gronenborn NMR structure of human restriction factor APOBEC3A reveals substrate binding and enzyme specificity Nat. Commun. 4 2013 1890
60. A. Ara, R.P. Love, and L. Chelico Different mutagenic potential of HIV-1 restriction factors APOBEC3G and APOBEC3F is determined by distinct single-stranded DNA scanning mechanisms PLoS Pathog. 10 2014 e1004024
61. M.A. Langlois, R.C. Beale, S.G. Conticello, and M.S. Neuberger Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities Nucleic Acids Res. 33 2005 1913 1923
62. R.M. Kohli, S.R. Abrams, K.S. Gajula, R.W. Maul, P.J. Gearhart, and J.T. Stivers A portable hot spot recognition loop transfers sequence preferences from APOBEC family members to activation-induced cytidine deaminase J. Biol. Chem. 284 2009 22898 22904
63. R.M. Kohli, R.W. Maul, A.F. Guminski, R.L. McClure, K.S. Gajula, H. Saribasak, M.A. McMahon, R.F. Siliciano, P.J. Gearhart, and J.T. Stivers Local sequence targeting in the AID/APOBEC family differentially impacts retroviral restriction and antibody diversification J. Biol. Chem. 285 2010 40956 40964
64. H. Huthoff, and M.H. Malim Identification of amino acid residues in APOBEC3G required for regulation by human immunodeficiency virus type 1 Vif and Virion encapsidation J. Virol. 81 2007 3807 3815
65. M.F. Bohn, S.M. Shandilya, J.S. Albin, T. Kouno, B.D. Anderson, R.M. McDougle, M.A. Carpenter, A. Rathore, L. Evans, A.N. Davis, J. Zhang, Y. Lu, M. Somasundaran, H. Matsuo, R.S. Harris, and C.A. Schiffer Crystal structure of the DNA cytosine deaminase APOBEC3F: the catalytically active and HIV-1 Vif-binding domain Structures 21 2013 1042 1050